Clinical trials: Human Papillomavirus Vaccines
Human Papillomavirus, Infection
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
PROJECT JUSTIFICATION: Cervical cancer is a serious public health problem in Brazil, and is the cause of significant morbidity and mortality among Brazilian women.
- Trial name
- NCT01159834
- Volunteers
- 1,574 people, healthy volunteers welcome
- Sponsor
- Barretos Cancer Hospital
HPV, HPV Vaccine
Digital Interventions to Increase HPV Vaccination Intentions Among Nigerian Caregivers
This study evaluates whether different types of digital health communication can increase parents' intention to vaccinate their daughters against human papillomavirus (HPV) in Nigeria.
- Trial name
- NCT07498075
- Testing
- Chatbot counseling, Misinformation-resistance pre-bunking inoculation, Short edutainment
- Where
- Nigeria
- Volunteers
- 3,340 people, healthy volunteers welcome
- Sponsor
- University of Pennsylvania
Human Papilloma Virus
SDH of HPV Vaccine Completion
The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child.
- Trial name
- NCT03709602
- Where
- United States
- Volunteers
- 3,076 people
- Sponsor
- Duke University
Uterine Cervical Cancer
Evaluation of Long-term HPV Vaccine Efficacy
Summary For ethical and practical reasons pre-licensure clinical efficacy phase III trials for GSK Biologicals' HPV-16/18 LI VLP AS04 vaccine used cervical intraepithelial grade 2 and above (CIN2+) lesions as surrogate efficacy…
- Trial name
- NCT01393470
- Testing
- Screening for cervical cancer
- Where
- 15 sites in Finland
- Volunteers
- 10,000 people, healthy volunteers welcome
- Sponsor
- Tampere University
HIV Infections, HPV Infection
Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women
In adult HIV-positive patients, data on the safety and immunogenicity of the quadrivalent HPV (qHPV) vaccine have been reported with excellent results (13 14); also, the results of a clinical trial of qHPV vaccine conducted in…
- Trial name
- 9-VPH-MVIH (NCT04270773)
- Testing
- Human Papillomavirus 9-valent Vaccine, Recombinant
- Where
- Spain
- Volunteers
- 158 people
- Sponsor
- University Hospital Virgen de las Nieves
Papillomavirus Infections, Papillomavirus Vaccines
Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers
Randomized clinical trial with two groups, with a test-retest model, with single-blind approach, using a probabilistic sampling and the population was mothers of girls aged 9 to 12 years from a public elementary school in the…
- Trial name
- NCT06854354
- Testing
- HPV Prevention Vaccine
- Where
- Mexico
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Hospital Univeristario Benemerita Universidad Autonoma de Puebla
Papilloma Viral Infection
Immunogenicity of Off-Schedule Dosing of HPV Vaccine
The purpose of this study is to gain a better understanding of the body's response to a human papillomavirus (HPV) (sexually transmitted disease), vaccine and booster shot.
- Trial name
- NCT01030562
- Where
- 7 sites in United States
- Volunteers
- 1,321 people, healthy volunteers welcome
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Papillomavirus Infections
GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)
This study will collect safety information on the use of GARDASIL™ in the Philippines.
- Trial name
- NCT01355003
- Volunteers
- 1,080 people, healthy volunteers welcome
- Sponsor
- Merck Sharp & Dohme LLC
Human Papillomavirus Vaccination, Emotions
Stories to Prevent (StoP) HPV Cancers
This randomized controlled trial (RCT) evaluates the association of a narrative communication intervention on human papillomavirus (HPV) vaccination rates among 9- to 12-year-olds.
- Trial name
- NCT06808776
- Testing
- Cancer survivor narrative, Healthy eating tips
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Milton S. Hershey Medical Center
Papillomavirus Infections
Immunobridging Study of 9- Valent Human Papillomavirus (9vHPV) Vaccine (V503) in Chinese Females 9 to 45 Years of Age (V503-024)
This study investigates the immunogenicity and safety of the 9vHPV vaccine in healthy Chinese females 9 to 45 years of age. The study consists of Stage I (Day 1 to Month 7) and Stage II (post Month 7 to Month 60).
- Trial name
- NCT03903562
- Testing
- V503
- Where
- 2 sites in China
- Volunteers
- 1,990 people, healthy volunteers welcome
- Sponsor
- Merck Sharp & Dohme LLC
Oropharyngeal Squamous Cell Carcinoma (SCC)
Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer
Background: Cancers in and around the mouth associated with human papilloma virus (HPV) are common. Two treatments (the drug pembrolizumab and the HPV vaccine PRGN-2009) have been shown to work well when used individually against…
- Trial name
- NCT05996523
- Testing
- PRGN-2009, Pembrolizumab, EKG
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- National Cancer Institute (NCI)
Infections, Papillomavirus
Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.
The main aim of this vaccine is to prevent cervical cancer in women. However, it could also be relevant to vaccinate selected groups of males.
- Trial name
- NCT00309166
- Testing
- Cervarix vaccine, Engerix-B vaccine
- Where
- 5 sites in Finland
- Volunteers
- 270 people, healthy volunteers welcome
- Sponsor
- GlaxoSmithKline
HPV Vaccine
Effectiveness of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination in China
This interventional study targets female students in junior middle school. It goal is to evaluate the effectiveness of a vaccine chatbot on HPV vaccine awareness and vaccination. The main questions it aims to answer are: 1.
- Trial name
- NCT06227689
- Testing
- Vaccine chatbot that offering HPV vaccine-related information
- Where
- 2 sites in China
- Volunteers
- 1,800 people, healthy volunteers welcome
- Sponsor
- Fudan University
HPV Vaccine Acceptability
A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men
The purposes of this study are to (1) identify predictors of Human papillomavirus (HPV) vaccine acceptability among college men based on the Health Belief Model through focus groups, (2) triangulate focus group results with a…
- Trial name
- NCT01431079
- Testing
- HPV vaccine acceptability
- Where
- United States
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- University of Cincinnati
Human Papillomavirus-Related Carcinoma
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
This study will test whether a tailored, online educational intervention increases HPV vaccine uptake and intent among female college students.
- Trial name
- NCT01769560
- Testing
- MeFirst Tailored Intervention
- Where
- United States
- Volunteers
- 661 people, healthy volunteers welcome
- Sponsor
- University of Michigan
Cervical Intraepithelial Neoplasia, Cervical Cancer
Impact of HPV Vaccine On The Prevalence Of HPV In Norway
The overall aim of the study is to assess the effect of school-based Human Papillomavirus (HPV) vaccination by comparing type-specific HPV prevalence between vaccinated and non-vaccinated women born in 1997.
- Conditions
- Cervical Intraepithelial Neoplasia, Cervical Cancer, Oropharyngeal Cancer
- Trial name
- NCT02934724
- Testing
- Self sample from vagina, Self sample from the oral cavity, Questionnaire
- Where
- Norway
- Volunteers
- 315 people, healthy volunteers welcome
- Sponsor
- Oslo University Hospital
Papilloma Virus, Human
IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody
This study is being done to evaluate how long the immune response from the Human Papilloma Virus (HPV) vaccine you / your child received persists.
- Trial name
- HPV (NCT01206556)
- Where
- 23 sites in United States, Puerto Rico
- Volunteers
- 97 people
- Sponsor
- International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Human Papilloma Virus
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
The educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute (NCI) and a small media intervention (i.e., video) that our research…
- Trial name
- NCT04611022
- Testing
- HPV Educational Intervention
- Where
- United States
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- University of Colorado, Denver
Human Papillomavirus Vaccination
SMS HPV Vaccine Reminders
This study will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health…
- Trial name
- SEARCH (NCT05151367)
- Testing
- Text message reminder
- Where
- 2 sites in United States, Uganda
- Volunteers
- 154 people, healthy volunteers welcome
- Sponsor
- Columbia University
HPV Infection
HPV Vaccine Immunity in High-risk Women
This is a single arm immunological study based in Vietnam. The study will examine human papillomavirus (HPV) vaccine responses in high-risk women (female-sex-worker; FSW).
- Trial name
- NCT04590521
- Testing
- Gardasil®, Merck
- Where
- Vietnam
- Volunteers
- 63 people, healthy volunteers welcome
- Sponsor
- Murdoch Childrens Research Institute